Based on the Healthequity Inc stock forecast from 0 analysts, the average analyst target price for Healthequity Inc is not available over the next 12 months. Healthequity Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Healthequity Inc is Slightly Bullish , which is based on 6 positive signals and 5 negative signals. At the last closing, Healthequity Inc’s stock price was EUR 90.50. Healthequity Inc’s stock price has changed by +0.00% over the past week, -6.22% over the past month and +53.39% over the last year.
No recent analyst target price found for Healthequity Inc
No recent average analyst rating found for Healthequity Inc
Company Overview Healthequity Inc
HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is based in Draper, Utah. Read Less
HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information...Read More
Frequently Asked Questions About Healthequity Inc (2HE:F) Stock
Stock Target Advisor's fundamental analysis for Healthequity Inc's stock is Slightly Bullish .
Unfortunately we do not have enough data on 2HE:F's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on 2HE:F's stock to indicate what its average analyst target is.
2HE:F stock's Price/Earning ratio is 83.63.
Our analysis grades 2HE:F stock's Price / Earning ratio at F. This means that 2HE:F stock's Price/Earning ratio is above 84% of the stocks in the Health Information Services sector in the F exchange.
Based on this 2HE:F may be a overvalued for its sector.
The last closing price of 2HE:F's stock was EUR 90.50.
The most recent market capitalization for 2HE:F is EUR 8.38B.
Unfortunately we do not have enough analyst data on 2HE:F's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Healthequity Inc's stock.
As per our most recent records Healthequity Inc has 3,126 Employees.
Healthequity Inc's registered address is 15 West Scenic Pointe Drive, Draper, UT, United States, 84020.
You can get more information about it from Healthequity Inc's website at https://www.healthequity.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
What not to like
Poor capital utilization
The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Healthequity Inc (2HE:F) Stock
Stock Target Advisor's fundamental analysis for Healthequity Inc's stock is Slightly Bullish .
Unfortunately we do not have enough data on 2HE:F's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on 2HE:F's stock to indicate what its average analyst target is.
2HE:F stock's Price/Earning ratio is 83.63.
Our analysis grades 2HE:F stock's Price / Earning ratio at F. This means that 2HE:F stock's Price/Earning ratio is above 84% of the stocks in the Health Information Services sector in the F exchange.
Based on this 2HE:F may be a overvalued for its sector.
The last closing price of 2HE:F's stock was EUR 90.50.
The most recent market capitalization for 2HE:F is EUR 8.38B.
Unfortunately we do not have enough analyst data on 2HE:F's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Healthequity Inc's stock.
As per our most recent records Healthequity Inc has 3,126 Employees.
Healthequity Inc's registered address is 15 West Scenic Pointe Drive, Draper, UT, United States, 84020.
You can get more information about it from Healthequity Inc's website at https://www.healthequity.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 2HE:F !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
